We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$107B
AUM Growth
-$4.88B
(-4.4%)
Cap. Flow
+$802M
Cap. Flow
% of AUM
0.75%
Top 10 Holdings %
Top 10 Hldgs %
28.03%
Holding
4,262
New
46
Increased
1,724
Reduced
2,093
Closed
87
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$78.7M |
| 2 |
XYZ
Block Inc
XYZ
|
+$49.3M |
| 3 |
Visa
V
|
+$46.1M |
| 4 |
Apple
AAPL
|
+$45.4M |
| 5 |
DoorDash
DASH
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$78.8M |
| 2 |
EXE
Expand Energy Corp
EXE
|
+$23.2M |
| 3 |
Williams-Sonoma
WSM
|
+$22.2M |
| 4 |
Broadcom
AVGO
|
+$20.3M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$19.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.67% |
| 2 | Financials | 14.43% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Galectin Therapeutics
GALT
$348M
| $20K | ﹤0.01% |
16,401
-1,129
| -6% | -$1.58K |
|
|
JKS
3352
JinkoSolar
JKS
$891M
| $19.9K | ﹤0.01% |
1,068
-400
| -27% | -$8.9K |
|
3353
Outlook Therapeutics
OTLK
$191M
| $19.7K | ﹤0.01% |
16,170
-171,880
| -91% | -$301K |
|
3354
Drilling Tools International
DTI
$80.1M
| $19.5K | ﹤0.01% |
8,244
-4,445
| -35% | -$13.7K |
|
3355
Braskem
BAK
$913M
| $19.5K | ﹤0.01% |
5,060
-21
| -0.4% | -$87 |
|
|
GCTS
3356
GCT Semiconductor Holding
GCTS
$235M
| $19.4K | ﹤0.01% |
11,862
-39,465
| -77% | -$84.2K |
|
3357
Scilex Holding
SCLX
$48.9M
| $19.4K | ﹤0.01% |
2,230
-194
| -8% | -$2.44K |
|
|
TSE
3358
DELISTED
Trinseo
TSE
| $19.4K | ﹤0.01% |
5,266
-2,613
| -33% | -$11.9K |
|
|
FRSX
3359
Foresight Autonomous Holdings
FRSX
$3.64M
| $19.3K | ﹤0.01% |
1,411
+415
| +42% | +$8.52K |
|
|
TLX
3360
Telix Pharmaceuticals
TLX
$3.9B
| $19.2K | ﹤0.01% |
+1,146
| New | +$20K |
|
3361
LanzaTech
LNZA
$69.8M
| $18.9K | ﹤0.01% |
779
-18
| -2% | -$1.62K |
|
|
BOLD
3362
Boundless Bio
BOLD
$65M
| $18.5K | ﹤0.01% |
12,231
+4,420
| +57% | +$9.16K |
|
3363
Q32 Bio
QTTB
$464M
| $18.4K | ﹤0.01% |
11,156
-94,388
| -89% | -$254K |
|
|
QVCGA
3364
DELISTED
QVC Group Inc Series A
QVCGA
| $18.3K | ﹤0.01% |
1,822
-1,744
| -49% | -$27.7K |
|
3365
Arm
ARM
$302B
| $17.9K | ﹤0.01% |
168
-148
| -47% | -$20.6K |
|
|
ELUX
3366
DELISTED
AKTIEB. ELECTROLUX B ADR SPNSD
ELUX
| $17.5K | ﹤0.01% |
1,080
-1,253
| -54% | -$20.4K |
|
3367
Sibanye-Stillwater
SBSW
$7.53B
| $17.5K | ﹤0.01% |
3,830
-8,960
| -70% | -$34K |
|
|
SNRE
3368
DELISTED
Sunrise Communications AG American Depositary Shares representing Class A shares
SNRE
| $17.5K | ﹤0.01% |
363
-1,068
| -75% | -$50K |
|
3369
RLX Technology
RLX
$2.46B
| $17.3K | ﹤0.01% |
9,185
-1,695
| -16% | -$3.76K |
|
3370
Bridger Aerospace
BAER
$74.1M
| $17.2K | ﹤0.01% |
15,246
+7,284
| +91% | +$16K |
|
3371
Eos Energy Enterprises
EOSE
$1.51B
| $17.2K | ﹤0.01% |
4,545
+3,292
| +263% | +$16K |
|
|
NIU
3372
Niu Technologies
NIU
$193M
| $17.1K | ﹤0.01% |
4,191
-3,343
| -44% | -$8.33K |
|
|
CMRX
3373
DELISTED
Chimerix, Inc.
CMRX
| $17.1K | ﹤0.01% |
+2,005
| New | +$11.1K |
|
|
HUYA
3374
Huya Inc
HUYA
$558M
| $16.5K | ﹤0.01% |
5,145
-1,288
| -20% | -$4.64K |
|
|
MTL.PR
3375
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
| $16.4K | ﹤0.01% |
13,618
| – | – |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2025 Portfolio in Review
As of Q1 2025, RhumbLine Advisers held 4,262 positions worth $107B, down 4.4% from $112B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.1%. RhumbLine Advisers opened 46 new positions and exited 87, leaving the 4,262-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2025 buy was Block Inc: 660,293 shares worth $35.9M.
- RhumbLine Advisers added most to iShares Russell 2000 ETF in Q1 2025, an estimated $78.7M increase.
- RhumbLine Advisers's biggest Q1 2025 reduction was Meta Platforms (Facebook), cutting an estimated $78.8M.
- RhumbLine Advisers fully exited Aspen Technology Inc in Q1 2025, selling an estimated $19.7M.
- RhumbLine Advisers's ten largest holdings make up 28% of its $107B portfolio in Q1 2025.
- RhumbLine Advisers opened 46 new positions and closed 87 in Q1 2025.
- RhumbLine Advisers's portfolio value fell 4.4% quarter-over-quarter to $107B.
Based on RhumbLine Advisers's 13F filing for Q1 2025, filed 8 Apr 2025.